TYRO3 is a key part of the tumor-associated macrophage (TAM) receptor-ligand complex, which are implicated in several hallmarks of cancer progression and involves in the acquisition of the resistance to sunitinib in renal cell carcinoma (Pinato et al., 2016). The gene discussed is TYRO3; the disease is renal cell carcinoma.